Rinda K. Sama
Net Worth
Last updated:
What is Rinda K. Sama net worth?
The estimated net worth of Mr. Rinda K. Sama is at least $23,599,091 as of 31 Jan 2024. He has earned $19,730,711 from insider trading and has received compensation worth at least $3,868,380 in Axonics, Inc..
What is the salary of Rinda K. Sama?
Mr. Rinda K. Sama salary is $644,730 per year as Chief Operating Officer in Axonics, Inc..
How old is Rinda K. Sama?
Mr. Rinda K. Sama is 46 years old, born in 1979.
What stocks does Rinda K. Sama currently own?
As insider, Mr. Rinda K. Sama owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Axonics, Inc. (AXNX) | Chief Operating Officer | 608 | $0 | $0 |
What does Axonics, Inc. do?
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Rinda K. Sama insider trading
Axonics, Inc.
Mr. Rinda K. Sama has made 47 insider trades between 2019-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 73,848 units of AXNX stock on 15 Apr 2021. As of 31 Jan 2024 he still owns at least 608 units of AXNX stock.
Axonics key executives
Axonics, Inc. executives and other stock owners filed with the SEC:
- Dr. Karen L. Noblett M.D., M.A.S. (62) Chief Medical Officer
- Mr. Alfred J. Ford Jr. (54) Chief Commercial Officer
- Mr. Danny L. Dearen (62) Pres & Chief Financial Officer
- Mr. Raymond W. Cohen (66) Chief Executive Officer & Director
- Mr. Rinda K. Sama (46) Chief Operating Officer